FDA-2024-0081-V181
Minor variation for application FDA-2024-0081. Minor variation: Analytical Method Change for Kcluximab — critical change
Variation Number
FDA-2024-0081-V181
Type
Minor
Application
Change
Status
Completed
Fee
€2,813
Submitted
—
Approved
—
Description
Minor variation: Analytical Method Change for Kcluximab — critical change